Scarica l'app Stockscreener
78.60
0.58%
0.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$78.15
Aprire:
$78.4
Volume 24 ore:
6.98M
Relative Volume:
0.81
Capitalizzazione di mercato:
$100.91B
Reddito:
$35.48B
Utile/perdita netta:
$4.64B
Rapporto P/E:
21.94
EPS:
3.582
Flusso di cassa netto:
$5.41B
1 W Prestazione:
+3.22%
1M Prestazione:
-5.55%
6M Prestazione:
-22.33%
1 anno Prestazione:
-2.86%
Intervallo 1D:
$78.21
$79.25
Intervallo di 1 settimana:
$76.03
$79.25
Portata 52W:
$74.40
$106.33
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Ripresa | Barclays | Overweight |
| 2026-02-09 | Aggiornamento | Needham | Hold → Buy |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2026-01-30 | Ripresa | Wells Fargo | Overweight |
| 2026-01-06 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Medtronic stock (IE00BTN1Y115): earnings momentum, portfolio moves and what’s next for diabetes an - AD HOC NEWS
SCRS and Medtronic Singapore sign MoU to boost colorectal surgery training - Healthcare Asia Magazine
Medtronic Singapore partners with Society of Colorectal Surgeons to strengthen surgical training - PR Newswire
Medtronic stock (IE00BTN1Y115): earnings, diabetes pivot and what’s next for the medtech giant - AD HOC NEWS
Medtronic PLC $MDT Position Decreased by Guinness Asset Management LTD - MarketBeat
Medtronic SPR Therapeutics Deal Expands Pain Portfolio As Shares Screen Undervalued - Yahoo Finance
List of 71 Acquisitions by Medtronic (May 2026) - Tracxn
Deal Dispatch: IMAX Mulls Potential Sale, Shein Buys Everlane, West Marine Bankruptcy - Benzinga
Can MDT Stock Gain From Its Planned Acquisition of SPR Therapeutics? - TradingView
Medtronic to create European software hub in Ireland - MedTech Dive
Pzena Investment Management LLC Reduces Stock Holdings in Medtronic PLC $MDT - MarketBeat
Diamond Hill Capital Management Inc. Lowers Stake in Medtronic PLC $MDT - MarketBeat
Global Retirement Partners LLC Increases Stake in Medtronic PLC $MDT - MarketBeat
Medtronic stock (IE00BTN1Y115): earnings beat and robotic surgery partnership in focus - AD HOC NEWS
MDT Stock Price, Quote & Chart | MEDTRONIC PLC (NYSE:MDT) - ChartMill
Medtronic to acquire SPR Therapeutics for $650m - Medical Device Network
BNY Mellon Dynamic Value Fund's Medtronic PLC(MDT) Holding History - GuruFocus
Latham Advises SPR Therapeutics in Acquisition by Medtronic - Latham & Watkins LLP
Medtronic to acquire Cleveland medical tech leader SPR Therapeutics for $650 Million - Ohio Tech News
Medtronic plans to acquire SPR Therapeutics - Medical Buyer
Precision Trading with Medtronic Plc. (MDT) Risk Zones - Stock Traders Daily
IFP Advisors Inc Boosts Stake in Medtronic PLC $MDT - MarketBeat
Gabelli Funds LLC Reduces Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic stock (IE00BTN1Y115): $650 million SPR Therapeutics deal puts chronic pain portfolio in fo - AD HOC NEWS
85 jobs boost as Medtronic announces European Software Development Hub in Galway - Galway Advertiser
Fast-growing Cleveland biotech firm SPR Therapeutics sold for $650M to Irish company - Crain's Cleveland Business
Medtronic’s SWOT analysis: stock navigates spin-off impact - Investing.com
Medtronic to buy SPR Therapeutics for about $650M - MedTech Dive
Medtronic plc stock (IE00BTN1Y115): SPR deal adds growth angle - AD HOC NEWS
Medtronic (MDT) Stock Slides as Company Announces $650M SPR Therapeutics Deal - Blockonomi
Medtronic (MDT) Stock: Shares Dip Amid $650M SPR Therapeutics Acquisition - CoinCentral
Medtronic data back renal denervation in the long term - MedTech Dive
Medtronic plans to buy SPR Therapeutics for $650 million to expand pain treatment options - Reuters
Medtronic stock rises as company acquires SPR Therapeutics for $650M - Investing.com Nigeria
Medtronic to acquire SPR Therapeutics for $650 million By Investing.com - Investing.com Australia
Medtronic announces intent to acquire SPR Therapeutics - marketscreener.com
Medtronic to Acquire SPR Therapeutics for $650 Million - marketscreener.com
Medtronic Plans to Acquire SPR Therapeutics for $650 Million - marketscreener.com
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain - PR Newswire
Medtronic PLC $MDT is Lazard Freres Gestion S.A.S.'s 10th Largest Position - MarketBeat
Suture Sleeve Kit Market Analysis 2036: Global North America Leads as Medtronic plc and Abbott Laboratories Expand - openPR.com
Resona Asset Management Co. Ltd. Cuts Stake in Medtronic PLC $MDT - MarketBeat
HighTower Advisors LLC Has $138.80 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $8.37 Million in Medtronic PLC $MDT - MarketBeat
GSA Capital Partners LLP Boosts Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic to create 85 jobs in Galway software hub - Business Post
Medtronic to acquire SPR Therapeutics for $650 million - Investing.com UK
Medtronic plc stock (IE00BTN1Y115): New products, pricing, and growth outlook - AD HOC NEWS
Medtronic Announces Leadership Transition in Neuroscience Portfolio - The Globe and Mail
Medtronic Whistleblower Suit Stayed Amid Settlement Talks - Law360
Medtronic plc agreed to acquire SPR Therapeutics, Inc. for approximately $650 million. - marketscreener.com
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):